Dean Ferrigno
Directeur Financier/CFO chez Arog Pharmaceuticals, Inc.
Profil
Dean Ferrigno is currently the CFO & Principal Accounting Officer at Arog Pharmaceuticals, Inc. He previously worked as the Vice President-Global Finance at SCILEX Pharmaceuticals, Inc. from 2015 to 2016.
He also worked as the Chief Accounting Officer & VP-Finance at Sorrento Therapeutics, Inc. Additionally, he was the Vice President-Finance at Statewide Clinical Trials Network of Texas from 2011 to 2013.
Mr. Ferrigno holds an MBA degree from Fairleigh Dickinson University.
Postes actifs de Dean Ferrigno
| Sociétés | Poste | Début |
|---|---|---|
Arog Pharmaceuticals, Inc.
 Arog Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arog Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company that focuses on the discovery, development and commercialization of drugs to treat unmet medical needs in oncology. It offers clinical trials for Acute Myeloid Leukemia, Gastrointestinal Stromal Tumor, and Glioma. The company was founded by Vinay K. Jain in 2010 and is headquartered in Dallas, TX. | Directeur Financier/CFO | 01/03/2018 |
Anciens postes connus de Dean Ferrigno
| Sociétés | Poste | Fin |
|---|---|---|
| SORRENTO THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 23/03/2018 |
SCILEX Pharmaceuticals, Inc.
 SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA. | Directeur Financier/CFO | 01/11/2016 |
Statewide Clinical Trials Network of Texas
 Statewide Clinical Trials Network of Texas Miscellaneous Commercial ServicesCommercial Services Statewide Clinical Trials Network of Texas is a non-profit organization that operates as an oncology research network. | Directeur Financier/CFO | 01/02/2013 |
Formation de Dean Ferrigno
| Fairleigh Dickinson University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SORRENTO THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Arog Pharmaceuticals, Inc.
Arog Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arog Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company that focuses on the discovery, development and commercialization of drugs to treat unmet medical needs in oncology. It offers clinical trials for Acute Myeloid Leukemia, Gastrointestinal Stromal Tumor, and Glioma. The company was founded by Vinay K. Jain in 2010 and is headquartered in Dallas, TX. | Health Technology |
SCILEX Pharmaceuticals, Inc.
SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA. | Health Technology |
Statewide Clinical Trials Network of Texas
Statewide Clinical Trials Network of Texas Miscellaneous Commercial ServicesCommercial Services Statewide Clinical Trials Network of Texas is a non-profit organization that operates as an oncology research network. | Commercial Services |
